Tag: antithyroid drugs
-
Progression Profile of Graves’ Disease After Loading-Dose Antithyroid Therapy: Insights from Brazzaville
Introduction Graves’ disease is an autoimmune thyroid disorder and the leading cause of hyperthyroidism worldwide. Its clinical course—marked by thyrotoxicosis, ocular manifestations, and immunological fluctuations—requires careful management beyond symptom control. This article discusses the progression profile of Graves’ disease after the initial phase of antithyroid therapy, specifically focusing on a loading-dose regimen used at the…
-
Progression Profile of Graves’ Disease After Initial Loading Dose Antithyroid Therapy at Brazzaville’s University Teaching Hospital
Introduction Graves’ disease is a leading autoimmune cause of hyperthyroidism, characterized by immune-mediated overactivity of the thyroid gland. The condition manifests with thyrotoxicosis, diffuse goiter, and a spectrum of systemic symptoms. In clinical practice, antithyroid medications are commonly used as first-line therapy to control thyroid hormone excess and to induce remission. This article reviews the…
-
Progression Profile of Graves’ Disease after Treatment with Antithyroid Medications in the Initial Phase with a Loading Dose at the University Teaching Hospital of Brazzaville
Introduction Graves’ disease is an autoimmune disorder that drives excessive thyroid hormone production, making it the leading cause of hyperthyroidism worldwide. Its clinical course and immunological behavior can be unpredictable, particularly during the initial treatment phase. In this study-style overview, we examine the progression of Graves’ disease after starting antithyroid medications, with a loading dose…